Pure Global

Application of Spectral Methods to Assess Gametes, Embryos, and Human Reproductive Capabilities - Trial NCT06266169

Access comprehensive clinical trial information for NCT06266169 through Pure Global AI's free database. This phase not specified trial is sponsored by Family Planning Center of Women's Welfare Clinic #44 of Pushkin District and is currently Recruiting. The study focuses on Infertility. Target enrollment is 1064 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06266169
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06266169
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Application of Spectral Methods to Assess Gametes, Embryos, and Human Reproductive Capabilities
Application of Spectral Methods to Assess the Potential of Gametes and Embryos, as Well as Human Reproductive Capabilities

Study Focus

Infertility

making artificial intelligence based decisions of gamete, embryo and endometrial potential

Interventional

other

Sponsor & Location

Family Planning Center of Women's Welfare Clinic #44 of Pushkin District

Saint Petersburg, Russian Federation

Timeline & Enrollment

N/A

Sep 20, 2023

Dec 31, 2025

1064 participants

Primary Outcome

Embryonic model performance,Gamete model performance,Endometrial model performance,Embryonic model clinical efficiency,Endometrial model clinical efficiency

Summary

Relevance of the research topic: At present, in the world, a kind of plateau in the
 efficiency of assisted reproductive technologies has been achieved, which ensures a birth
 rate of 30% per embryo transfer. At the same time, a relatively high (15-20%) and stable rate
 of miscarriages is preserved. Until now, no effective methods for assessing the potential of
 gametes and embryos, as well as human reproductive capabilities, have been offered. In these
 conditions, to increase the rate of births after IVF, clinicians have to increase the number
 of transferred embryos at a time, however, this leads to a sharp increase in complications of
 IVF, such as multiple pregnancy. In addition, until today, the clinical effectiveness of
 assessing the potential of endometrium using gene expression determination methods has not
 been shown. Therefore, to ensure the effectiveness and safety of infertility treatment, it is
 necessary to develop methods for predicting the potential of gametes and embryos, as well as
 human reproductive capabilities. For this purpose, the investigators assume to use Raman
 spectroscopy of the environment obtained from the objects of research, as well as fluorescent
 spectroscopy of endometrium. The objects of the research are gametes (spermatozoa) and
 embryos, used culture medium, endometrium. The subject of the study is the set of factors,
 that exists in the objects of research and their ability to determine the outcomes of
 infertility treatment.

ICD-10 Classifications

Female infertility
Male infertility
Female infertility, unspecified
Female infertility of other origin
Female infertility of uterine origin

Data Source

ClinicalTrials.gov

NCT06266169

Non-Device Trial